Clinical data | |
---|---|
Trade names | Equioxx, Previcox |
AHFS/Drugs.com |
|
License data | |
Routes of administration | By mouth |
ATCvet code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H20O5S |
Molar mass | 336.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).[2][4][8] Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[9] Firocoxib is not intended or approved for use in human medicine.[2][4][5][6][10]
Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004,[11] and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.[12][13]
Firocoxib is also available as a generic medication for horses[13] and for dogs.[11]
| |
---|---|
pyrazolones / pyrazolidines |
|
salicylates |
|
acetic acid derivatives and related substances |
|
oxicams |
|
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) |
|
COX-2 inhibitors (coxibs) |
|
other |
|
NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
|
This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |